PPT-Exploring the health outcomes of various pan-Canadian cervical cancer screening programs

CSEB June 10 2016 Jason Lacombe 1 Saima Memon 1 Cindy Gauvreau 1 Cathy Popadiuk 2 William Flanagan 3 Claude Nadeau 3 Andrew J Coldman 1 Michael C Wolfson 4. . KrisEmily. . McCrory. , MD. Objectives:. Review cervical cancer epidemiology and . pathophysiology. Identify the role of the Human . Papilloma. Virus in cervical cancer. Explain the use of HPV testing in cervical cancer screening. Based on 2012 Guidelines & Recommendations. Sarah Lamanuzzi, MD, FAAFP. Disclosures. I have no disclosures other than: the ASCCP gave permission for use of their slide content.. The American Society for Colposcopy and Cervical Pathology. “Cervical Cancer Screening Recommendations, . Based on the 2012 Recommendations (ASCCP). Sarah Lamanuzzi, MD, FAAFP. Disclosures. I have no disclosures other than: the ASCCP gave permission for use of their slide content.. The American Society for Colposcopy and Cervical Pathology. “Cervical Cancer Screening Recommendations, . Hazel Lewis. Public Health Physician. Wellington. Cartwright Forum, 7 August 2015. NCSP. -. R. centralised. 1965. 1990. 2000. 1988. Cartwright Report. NCSP . established . In 14 AHB. 1996. NSU. Gisborne Inquiry (CSI). Robert Music. Chief Executive. The impact of cervical . cancer. “As long as I can remember I had wanted children and the most distressing part of this illness is that I. . will never be able to.”. Annual CPCRN Meeting, Chicago. Tuesday, May 24. th. . Lead: Karen Glanz, PhD, MPH. Participating Sites: . UPenn. , UNC, . UWash. , CDC, NCI. This presentation was supported by Cooperative Agreement Number U48 DP005053 from the Centers for Disease Control and Prevention. The findings and conclusions in this presentation are those of the author(s) and do not necessarily represent the official position of the Centers for Disease Control and Prevention. . Judith.rosen.1.ctr@us.af.mil. MHSPHP: Patients and Metrics. 2. Patient Detail View. Overview. Breast Cancer Screening. Clinical recommendations versus HEDIS. Metric versus Lists. Cervical Cancer Screening. 141. st. APHA Annual Meeting. November 2013. Richard A. Crosby, PhD. University of Kentucky College of Public Health. Department of Health Behavior. . Presenter Disclosures. (1) The following personal financial relationships with commercial interests relevant to this presentation existed during the past 12 months:. Nino Kiknadze. Associated Professor of Family . Medicine . Department. Tbilisi State Medical University. Georgian Representative in EURACT. KIEV November 2016. SCREENING PROGRAMS IN GEORGIA. Cancer Screening. CERVICAL CANCER. 4th most common cancer in women worldwide. CERVICAL CANCER. 4th most common cancer in women worldwide. >250,000 deaths/year. CERVICAL CANCER. 4th most common cancer in women worldwide. Cervical cancer. Cervical cancer is one of the . most preventable . cancers. Human papillomavirus (HPV). Over 99% of cervical cancer is caused by HPV. ‘Common cold of sexual activity’. Usually no symptoms. Host. – . Mandeep Singh . Ahluwalia. Speakers. – Mandeep Ahluwalia, Karen Burgess, Bikram Raychaudhuri, Jane Lodge and Amy Dissanayake. . . . The webinar will commence at 1pm. Please remember to turn off your mics and cameras. . Kelly S, Mc Fadden SL. School of Life and Health Sciences, University of Ulster . Jordanstown. . Introduction. Aim. Methodology. The aetiological factors associated with cervical cancer are relatively unknown, however scientific evidence links persistent infection with human papilomavirus (HPV) and the development of cervical carcinomas. . (Preliminary Results). Hawa Camara. |. November 17. th. , 2018. Facts about Cervical cancer in PNG. 2. Experiences of PoC HPV-DNA cervical screening in PNG. Need for improved screening services. 3.